Todas las fotos(1)

Documentos

Certificado de origen (COO)/COA

I0361000

Ipratropium bromide impurity B

Name: Ipratropium bromide impurity B
Brand: SIAL

European Pharmacopoeia (EP) Reference Standard

Sinónimos:

(1R,3r,5S,8s)-3-[[(2RS)-3-Hydroxy-2-phenylpropanoyl]oxy]-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]octane bromide

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización

Todas las fotos(1)

About This Item

Fórmula empírica (notación de Hill):

C₂₀H₃₀BrNO₃

Número de CAS:

58073-59-9

Peso molecular:

412.36

UNSPSC Code:

41116107

NACRES:

NA.24

Productos recomendados

Slide 1 of 10

1 of 10

Y0000276

Ipratropium impurity A

BP930

Ciprofloxacin impurity standard

USP

1347529

Ipratropium bromide Related Compound B

USP

1347530

Ipratropium bromide Related Compound C

X0101000

Xylometazoline impurity A

BP626

8s-Isopropyl-3β-hydroxytropanium bromide

Supelco

PHR3017

Ipratropium Bromide Related Compound A

Y0000757

(−)-Riboflavina

USP

1347518

Ipratropium bromide Related Compound A

USP

1492266

Palonosetron Related Compound E

grade

pharmaceutical primary standard

API family

ipratropium

manufacturer/tradename

EDQM

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

2-8°C

¿Está buscando productos similares? Visita Guía de comparación de productos

Categorías relacionadas

Patrones de las farmacopeas y de los institutos metrológicos

Patrones de referencia analítica | Sigma-Aldrich

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Ipratropium bromide impurity B EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.

related product

Referencia del producto

Descripción

Precios

signalword

Warning

hcodes

H302

pcodes

P264 - P270 - P301 + P312 - P501

Hazard Classifications

Acute Tox. 4 Oral

Storage Class

11 - Combustible Solids

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificados de análisis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Atención al cliente

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Efficacy and safety of eco-friendly inhalers: focus on combination ipratropium bromide and albuterol in chronic obstructive pulmonary disease.

Ralph J Panos

International journal of chronic obstructive pulmonary disease, 8, 221-230 (2013-05-10)

Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality and its treatment is critical to improve quality of life, reduce symptoms, and diminish the frequency of COPD exacerbations. Due to the harmful environmental effects of pressurized

The utility of cold-preserved human hepatocytes in studies on cytochrome P450 induction and hepatic drug transport.

Sanja Juric et al.

Xenobiotica; the fate of foreign compounds in biological systems, 43(9), 785-791 (2013-04-11)

Human hepatocytes that had been cold-preserved in SureTran(TM) matrix (Abcellute Ltd, Cardiff, UK) were used for studies on cell viability, cytochrome P450 (CYP) 3A4, 2B6 and 1A2 induction and hepatic drug transporters. It has recently been shown that basal CYP

COPD patient satisfaction with ipratropium bromide/albuterol delivered via Respimat: a randomized, controlled study.

Gary T Ferguson et al.

International journal of chronic obstructive pulmonary disease, 8, 139-150 (2013-05-10)

Ipratropium bromide/albuterol Respimat inhaler (CVT-R) was developed as an environmentally friendly alternative to ipratropium bromide/albuterol metered-dose inhaler (CVT-MDI), which uses a chlorofluorocarbon propellant. The objective of this study was to evaluate patient satisfaction, device usage, and long-term safety of CVT-R

Comparative effectiveness of tiotropium and ipratropium in prevention of hospital readmission for COPD: a population-based cohort study.

Yuko Kawasumi et al.

Clinical therapeutics, 35(4), 523-531 (2013-03-16)

In the treatment of chronic obstructive pulmonary disease (COPD), tiotropium bromide has a longer duration of action than ipratropium bromide; however, tiotropium bromide is a more expensive alternative treatment. At issue is whether tiotropium reduces the risk for hospital readmissions

Predictors of adherence to inhaled medications.

John C Huetsch et al.

Journal of general internal medicine, 28(6), 759-759 (2013-03-27)

Ver todos los artículos relacionados

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico